Search
No relevant pages have been found
Number of relevant news: 5
Survival benefit of cetuximab for metastatic colorectal cancer
benefit of cetuximab for metastatic colorectal... (mCRC), and found that the addition of Erbitux (cetuximab) to standard chemotherapy (FOLFIRI) in patients with KRAS wild-type disease... cetuximab, advanced bowel...
Studies unpick why bowel cancers become resistant to treatment
additional drug to help curb this resistance. Cetuximab and panitumumab work by blocking a protein called EGFR on cancer cells. This... cancer, resistance, EGFR, KRAS, cetuximab,...
Breast cancer gene provides vital clue to bowel cancer drug resistance
bowel cancer patients treated with either cetuximab or panitumumab. These drugs are part of a raft of new targeted treatments...
New type of bowel cancer discovered
were more aggressive and resistant to the drug cetuximab, which can be used to treat the disease. Cetuximab targets a molecule called...
Research points to why some colorectal cancers recur after treatment
Cetuximab is one of the key therapies for metastatic colorectal cancer. Yet the cancer... about how EGFR renders cancer cells resistant to cetuximab antibody therapy," said Mien Chie Hung, Ph.D., chair of Molecular and Cellular... cancer (mCRC), extracellular methylation, cetuximab...